Express Scripts Beats On Top-Line, Misses on Bottom-Line -- Market Talk

FeaturesDow Jones Newswires

18:25 ET - Express Scripts' 3Q adjusted EPS matches analyst estimates but revenue comes in below Wall Street expectations. The pharmacy benefits management company also lifts the low-end of its EPS guidance for the year to a range of $6.97-$7.05 from the previous $6.95-$7.05. (imani.moise@wsj.com; @moisenoise)

(END) Dow Jones Newswires

Continue Reading Below

October 24, 2017 18:40 ET (22:40 GMT)